Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
Authors
Keywords
-
Journal
BMC Psychiatry
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-08-11
DOI
10.1186/s12888-023-05017-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior
- (2021) Carla M. Canuso et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With Intent
- (2021) Jennifer Voelker et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Frequency of rehospitalization after hospitalization for suicidal ideation or suicidal behavior in patients with depression
- (2020) M. Soledad Cepeda et al. PSYCHIATRY RESEARCH
- Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
- (2020) Dawn F Ionescu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom
- (2020) Tom Denee et al. CURRENT MEDICAL RESEARCH AND OPINION
- Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
- (2020) Larry Alphs et al. PSYCHIATRY RESEARCH
- Meta-analysis of suicide rates in the first week and the first month after psychiatric hospitalisation
- (2019) Daniel Chung et al. BMJ Open
- Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?
- (2019) Dominic Pilon et al. JOURNAL OF AFFECTIVE DISORDERS
- Esketamine: a glimmer of hope in treatment-resistant depression
- (2019) Upinder Kaur et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Epidemiology of Suicide and the Psychiatric Perspective
- (2018) Silke Bachmann International Journal of Environmental Research and Public Health
- SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM
- (2016) Jorge Lopez-Castroman et al. DEPRESSION AND ANXIETY
- Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study
- (2015) Ellen B. Dennehy et al. CURRENT MEDICAL RESEARCH AND OPINION
- Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up
- (2014) W. W. IsHak et al. ACTA PSYCHIATRICA SCANDINAVICA
- Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study
- (2014) Jong-Min Woo et al. Health and Quality of Life Outcomes
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
- (2011) D. Wasserman et al. EUROPEAN PSYCHIATRY
- Incidence and Predictors of Suicide Attempts in DSM–IV Major Depressive Disorder: A Five-Year Prospective Study
- (2010) K. Mikael Holma et al. AMERICAN JOURNAL OF PSYCHIATRY
- Development and reliability of a structured interview guide for the Montgomery-Åsberg Depression Rating Scale (SIGMA)
- (2008) Janet B. W. Williams et al. BRITISH JOURNAL OF PSYCHIATRY
- Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder
- (2008) Josephine A. Mauskopf et al. DEPRESSION AND ANXIETY
- Higher-risk periods for suicide among VA patients receiving depression treatment: Prioritizing suicide prevention efforts
- (2008) Marcia Valenstein et al. JOURNAL OF AFFECTIVE DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started